LINC00941 and pulmonary fibrosis: The results showed that DME treatment lessened pulmonary fibrosis, but the lncIAPF overexpression group had severe pulmonary fibrosis and more collagen deposition, which reversed the anti-pulmonary fibrosis of DME (Figure 7C).